20328 ⎘
Medicinal preparations containing organic active ingredients; Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole 1,3-Diazoles
METHOD FOR THE TREATMENT OR PREVENTION OF LOWER URINARY TRACT SYMPTOMS
#1502Phenylsulfoxyoxazole compound inhibitors of urea transporters
#1503Treatment of conditions related to shock
#1504Manufacture, compositions and uses of coagulation factor VIIa modulator
#15051, 3-Dihydroimidazoles for Treating Cardiovascular Disorders
#1506PHARMACEUTICAL COMPOSITION FOR USE IN THE TREATMENT AND/OR THE PREVENTION OF OSTEOARTICULAR DISEASES
#1507Method for treating proliferative disorders associated with mutations in c-Met
#1508Sugar Free Chewable Tablets
#1509TREATMENT OF MELANOMA WITH ALPHA THYMOSIN PEPTIDES IN COMBINATION WITH A KINASE INHIBITOR
#1510LARGE CONDUCTANCE CALCIUM-ACTIVATED K CHANNEL OPENER
#1511Absorbable crystalline copolyester-based bioactive hydroforming luminal liner compositions
#1512Absorbable crystalline polyether-ester-urethane-based bioactive luminal liner compositions
#1513Method for inhibiting topoisomerase II
#1514Dicationic compounds which selectively recognize G-quadruplex DNA
#1515Compositions for treating amyloid associated diseases
#1516DRUG DEPOTS FOR TREATMENT OF PAIN AND INFLAMMATION IN SINUS AND NASAL CAVITIES OR CARDIAC TISSUE
#1517Method and therapeutic/cosmetic topical compositions for the treatment of rosacea and skin erythema using α-adrenoceptor agonists
#1518Compounds, formulations, and methods for treating or preventing inflammatory skin disorders
#1519Enhanced migraine treatments based on ghrelin mimetics
#1520BENZIMIDAZOLIDINONE DERIVATIVES AS MUSCARINIC AGENTS
#1521PAIN REMEDY CONTAINING ROCK INHIBITOR
#1522Pharmaceutical preparations containing highly volatile silicones
#1523Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions
#1524METHOD FOR REDUCING GASTROINTESTINAL ADVERSE EFFECTS OF CYTOTOXIC AGENTS
#1525METHODS OF TREATING HEPATIC ENCEPHALOPATHY
#1526Compositions and methods for treatment of diseases and conditions with increased vascular permeability
#1527Compositions comprising bile acid sequestrants for treating esophageal disorders
#1528Antifungal pharmaceutical composition
#1529Mitochondria-targeted antioxidant prodrugs and methods of use
#1530Method to inhibit ischemia and reperfusion injury
#15314-PHENYLIMIDAZOLE-2-THIONE TYROSINASE INHIBITORS AND TREATMENT OR PREVENTION OF PIGMENTARY DISORDERS THEREWITH
#1532COMBINATIONS USEFUL FOR THE TREATMENT OF NEURONAL DISORDERS
#1533Amides of hyaluronic acid and the derivatives thereof and a process for their preparation
#1534Functionalized drugs and polymers derived therefrom
#1535Gastric acid secretion inhibiting composition
#1536Methods involving aldose reductase inhibitors
#1537Compounds, compositions and methods comprising heteroaromatic derivatives
#1538Dual acting prodrugs
#1539PHARMACEUTICAL FORMULATIONS
#1540Topical formulation
#1541Neurodegenerative diseases and methods of modeling
#1542Compounds, Formulations, and Methods for Treating or Preventing Inflammatory Skin Disorders
#1543Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP-1) compound or a melanocortin-4 receptor (MC4) agonist peptide
#1544Inhibitors of mycobacterium tuberculosis malate synthase, methods of making and uses thereof
#1545Method of treatment using alpha-1-adrenergic agonist compounds
#1546Transdermal therapeutic system comprising ion pair microreservoirs
#1547STABLE METRONIDAZOLE GEL FORMULATIONS
#1548Hydrophilic foam and pharmaceutical dosage form employing the same
#1549Immunocompetent xenograft model
#1550Oligosaccharide Aldonic Acids and Their Topical Use
#1551METHODS FOR PREVENTING, POSTPONING OR IMPROVING THE OUTCOME OF SPINAL DEVICE AND FUSION PROCEDURES
#1552LYOPHILIZED PHARMACEUTICAL COMPOSITIONS AND METHODS OF MAKING AND USING SAME
#1553Nitric oxide amino acid ester compound, compositions for increasing nitric oxide levels and method of use
#1554Methods of treating rheumatoid arthritis
#1555Thiadiazolidinone derivatives
#1556Anti-parasitic methods and compositions utilizing diindolylmethane-related indoles
#1557COMPOUNDS ACTING ON THE SEROTONIN TRANSPORTER
#1558Compositions for transfection of oligonucleotides active for gene silencing and their biological and therapeutical applications
#1559Aqueous compositions containing metronidazole
#1560NEUROPROTECTIVE MODULATION OF NMDA RECEPTOR SUBTYPE ACTIVITIES
#1561Solubilizing of metronidazole
#1562USE OF ARCHAEA TO MODULATE THE NUTRIENT HARVESTING FUNCTIONS OF THE GASTROINTESTINAL MICROBIOTA
#1563NOVEL REGIMENS FOR TREATING DISEASES AND DISORDERS
#1564SUBSTITUTED IMIDAZOLE COMBINATIONS
#1565METHODS FOR PREVENTING, POSTPONING OR IMPROVING THE OUTCOME OF INVASIVE SPINAL PROCEDURES
#1566Urea and sulfamide derivatives as inhibitors of TAFIa
#1567Irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis
#1568USE OF SUBSTITUTED GLYCERIN DERIVATIVES FOR PRODUCING A PHARMACEUTICAL PREPARATION
#1569Compounds, formulations, and methods for ameliorating telangiectasis
#1570ALPHA-2B ADRENERGIC RECEPTOR AGONIST AND SEROTONIN-NOREPINEPHRINE REUPTAKE INHIBITOR COMPOSITIONS FOR TREATING CHRONIC PAIN
#1571Malonyl-CoA decarboxylase inhibitors useful as metabolic modulators
#1572METHODS AND COMPOSITIONS FOR THE TREATMENT OF MALIGNANT MELANOMA, BREAST, PROSTATE, COLON, PAPILLARY THYROID AND PANCREATIC CANCER
#1573Control of blood vessel physiology to treat skin disorders
#1574Electrical stimulation method for treatment of peripheral neuropathy
#1575Synthetic triterpenoids and methods of use in the treatment of disease
#1576Use of levo-ornidazole in the preparation of anti-anaerobic bacteria infection drugs
#1577Methods of treating diarrhea caused by small intestinal bacterial overgrowth
#1578Compounds, Compositions and Methods Comprising Heteroaromatic Derivatives
#1579Antibiotic combinations for providing total solution to the treatment of infections
#1580USE OF BIARYLCARBOXAMIES IN THE TREATMENT OF HEDGEHOG PATHWAY-RELATED DISORDERS
#1581Mitochondria-Targeted Antioxidant Prodrugs and Methods of Use
#1582METHODS FOR THE TREATMENT OF BRAIN EDEMA
#1583Palatable, solid oral formulations for male chemical sterilization
#1584METHODS INVOLVING ALDOSE REDUCTASE INHIBITION
#1585Arthroscopic irrigation solution and method for peripheral vasoconstriction and inhibition of pain and inflammation
#1586AQUEOUS SOLVENT SYSTEM FOR SOLUBILIZATION OF AZOLE COMPOUNDS
#1587BCRP/ABCG2 inhibitor
#1588Compositions Including Relatively Water Insoluble/Unwettable Drugs And Methods For Using Same
#1589Biotherapeutic compositions comprising probiotic escherichia coli and uses thereof
#1590Compositions and Methods for Transmucosal Delivery of Lofexidine
#1591TREATMENT FOR CUTANEOUS T CELL LYMPHOMA
#1592Kinesin inhibitors as cancer therapeutics
#1593SELECTIVE SUBTYPE ALPHA 2 ADRENERGIC AGENTS AND METHODS FOR USE THEREOF
#1594COMBINED NSAID AND ACID BLOCKER FORMULATION AND METHOD
#1595Compounds, Compositions and Methods for the Treatment of Islet Amyloid Polypeptide (IAPP) Accumulation in Diabetes
#1596Methods and compositions for treating feline hyperthyroidism
#1597Methods of treating cognitive dysfunction by modulating brain energy metabolism
#1598Drug Combinations
#1599Selective inhibitors of human corticosteroid synthases
#1600High stability aqueous gels comprising metronidazole and methods for the preparation thereof
#1601Topical combination therapy for treating acne
#1602Use of combination preparations comprising antifungal agents
#1603Treatment of sepsis and inflammation with alphaadrenergic antagonists
#1604COMPOSITIONS, METHODS, AND SYSTEMS FOR RAPID INDUCTION AND MAINTENANCE OF CONTINUOUS REM SLEEP
#1605-disubstituted aminoalkylbiphenyl antagonists of prostaglandin Dreceptors
#1606Sulphamides for treatment of cancer
#1607Methods and compositions for increasing solubility of azole drug compounds that are poorly soluble in water
#1608Use of compounds of formula A-R-Xo pharmaceutically acceptable salts thereof for producing a pharmaceutically preparations
#1609Method and agent for inducing apoptosis/cell death in leukemia cells
#1610Compositions and methods for treating vaginal infections and pathogenic vaginal biofilms
#1611Composition for soft contact lens and adsorption suppressing method
#1612MEDICAL ARTICLES FOR THE TREATMENT OF TUMORS
#1613AVERMECTIN/METRONIDAZOLE COMPOSITIONS FOR TREATING AFFLICTIONS OF THE SKIN, E.G., ROSACEA
#1614Pharmaceutical Composition Comprising an Amide Derivative
#1615Compositions and methods for treating lysosomal disorders
#1616NOVEL COLORED SOLUTIONS OF INJECTABLE DRUGS AND THEIR PHARMACEUTICALLY ACCEPTABLE SALTS
#1617Layered drug delivery polymer monofilament fibers
#1618USE OF N-AMINOIMIDAZOLE CYTOPROTECTIVE COMPOUNDS FOR TREATING CELL DEATH AND/OR GSK-3 MEDIATED DISEASES
#1619USE OF ADSORBENT CARBON MICROSPHERES TO TREAT POUCHITIS
#1620Methods and compositions for treating metabolic disorders
#1621Bacterial intraoral disease treatment composition, washing treatment solution, hemostatic treatment solution, and bacterial intraoral disease treatment method
#1622Effervescent compositions comprising phosphonates and methods related thereto
#1623COSMETIC AND PHARMACEUTICAL COMPOSITIONS COMPRISING ACE INHIBITORS AND/OR ANGIOTENSIN II RECEPTOR ANTAGONISTS
#1624Method for treating congestive heart failure
#1625Method for treating diabetic nephropathy
#1626-based compositions and uses thereof
#1627METHOD OF TREATMENT OF CARDIAC AND/OR RENAL FAILURE USING A CALCIUM CHANNEL BLOCKER AND AN ANGIOTENSIN CONVERTING ENZYME INHIBITOR OR AN ANGIOTENSIN II RECEPTOR BLOCKER
#1628Compositions and Methods for Treating Cancer
#1629Carisoprodol, Phenytoin and Fosphenytoin Articles and Methods
#1630Compounds, compositions and methods for the treatment of beta-amyloid diseases and synucleinopathies
#1631Selective inhibitors of human corticosteroid syntheses
#1632Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK
#1633Pharmaceutical for prevention or treatment of bone metabolic disease
#1634Infection and treatment of neoplasms with vesicular stomatitis virus
#1635Method of selectively inhibiting PKCiota
#1636Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulators
#1637Inhibitors of Dipeptidylpeptidase IV
#1638Use
#1639Treatment of Post-Traumatic Stress Disorder
#1640Release-control composition
#1641Inhibitors for steroid response elements and related methods
#1642Methods for Treating Dependence
#1643Treatment of Depressive Disorders
#1644Rage Antagonists As Agents To Reverse Amyloidosis And Diseases Associated Therewith
#1645INTRAVAGINAL TREATMENT OF VAGINAL INFECTIONS WITH METRONIDAZOLE COMPOSITIONS
#1646PAIN REMEDY CONTAINING ROCK INHIBITOR
#1647DELAYING THE AGEING PROCESS AND DISORDERS CAUSED BY AGEING
#1648Dual-acting imidazole antihypertensive agents
#1649Inhibitors of glutaminyl cyclase
#1650Methods of treating a subject suffering from irritable bowel syndrome
#1651N-(2-(hetaryl)aryl) arylsulfonamides and N-(2-(hetaryl) hetaryl arylsulfonamides
#1652Lofexidine enantiomers for use as a treatment for CNS disease and pathologies and its chiral synthesis
#1653Drug combination for the treatment of skin disorders
#1654Topical compositions containing metronidazole
#1655Methods and compositions for treating acne and other infectious diseases
#1656Inhibitors against activation of NF-kappaB
#1657Antiviral drugs for treatment of arenavirus infection
#1658Topical compositions containing metronidazole
#1659Topical compositions containing metronidazole
#1660Topical compositions containing metronidazole
#1661Dissolution of Arterial Cholesterol Plaques by Pharmacologically Induced Elevation of Endogenous Bile Salts
#1662FULVENE AND FULVALENE ANALOGS AND THEIR USE IN TREATING CANCERS
#1663Beta2-Adrenergic Receptor Agonists
#1664Dual-acting antihypertensive agents
#1665Melanocortin-4 receptor binding compounds and methods of use thereof
#1666Bisamide inhibitors of hedgehog signaling
#1667Synergistic Formulation for Preventing and/or Treating Diabetes
#1668Controlling Clostridium difficile-Associated Disease in the Gastrointestinal Tract
#1669COMPOSITIONS AND METHODS FOR PROTECTION AGAINST CARDIAC AND/OR CENTRAL NERVOUS SYSTEM TISSUE INJURY BY INHIBITING SPHINGOSINE-1-PHOSPHATE LYASE
#1670Carisoprodol and Phenytoin Methods
#1671MEDICAMENT FOR TREATMENT OF NEURODEGENERATIVE DISEASES
#1672Methods for evaluating and implementing prostate disease treatments
#1673Synthetic triterpenoids and tricyclic-bis-enones for use in stimulating bone and cartilage growth
#1674ORAL ANTIMICROBIAL PHARMACEUTICAL COMPOSITIONS
#1675Use of Metronidazole For Preparing a Pharmaceutical Composition For Treating Pathologies Related to the B-Type Receptor of Interleukin 8 and/or to a Pacap Type 1 Receptor
#1676Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
#1677Compounds, methods and formulations for the oral delivery of a glucagon-like peptide (GLP)-1 compound or a melanocortin-4 receptor (MC4) agonist peptide
#1678Modified azole compounds as antifungal and antibacterial agents
#1679Nanoparticulate statin formulations and novel statin combinations
#1680Treatment of Epilepsy
#1681Derivatives of Aryl (or Heteroaryl) Azolylcarbinols (in Particular Cizolirtin Citrate) for the Treatment of Opioid Addiction
#1682Compositions for treating amyloid associated diseases
#1683Avermectin/metronidazole compositions for treating afflictions of the skin, e.g., rosacea
#1684CLEANSER COMPOSITION
#1685Angiogenesis inhibitors
#1686PREVENTING PATHOLOGICAL NERVE CELL SUICIDE (NEUROAPOPTOSIS) IN IMMATURE NERVOUS SYSTEMS
#1687Modified Azole Compounds As Antifungal and Antibacterial Agents
#1688METABOTROPIC GLUTAMATE RECEPTOR ACTIVATOR
#1689Use of Levo-Ornidazole For Preparing Anti-Parasitic Infection Drug
#1690Nonsedating Alpha-2 Agonists
#1691NEUROPROTECTION BY BLOOD FLOW STABILIZATION
#1692Vascular irrigation solution and method for inhibition of pain, inflammation, spasm and restenosis
#1693Solubilizing of metronidazole
#1694Cytochrome P450 Oxidase Inhibitors and Uses Thereof
#1695Method for increasing the solubility of betacyclodextrin
#1696ALPHA-2B RECEPTOR AGONIST AND ACID REDUCER COMPOSITIONS FOR TREATING GASTROINTESTINAL MOTILITY DISORDERS
#1697PAN-ALPHA-2 RECEPTOR AGONIST AND ACID REDUCER COMPOSITIONS FOR TREATING GASTROINTESTINAL MOTILITY DISORDERS
#1698Unit dose formulations and methods of treating thrombosis with an oral factor Xa inhibitor
#1699ALPHA-2B RECEPTOR AGONIST AND ANTICONVULSANT COMPOSITIONS FOR TREATING CHRONIC PAIN
#1700PAN-ALPHA-2 RECEPTOR AGONIST AND RELAXANT COMPOSITIONS FOR TREATING GASTROINTESTINAL MOTILITY DISORDERS
#1701PAN-ALPHA-2 RECEPTOR AGONIST AND 5HT4 SEROTONIN RECEPTOR COMPOSITIONS FOR TREATING GASTROINTESTINAL MOTILITY DISORDERS
#1702Method and system for enhancing self-treatment of onychomycosis
#17032-((2-thioxo-2,3-dihydro-1H-imidazol-4-yl)methyl)-3,4-dihydronaphthalen-1(2H)-one
#1704Compositions for the reversal and detoxification of anesthetics and other compounds and methods of their use
#1705ANTI-GLYCATION AGENTS FOR PREVENTING AGE-, DIABETES-, AND SMOKING-RELATED COMPLICATIONS
#1706Inflammation therapy
#1707COMPOSITIONS AND METHODS FOR TREATING SEIZURES
#1708Cosmetic and pharmaceutical foam
#1709Method of treating or preventing central nervous system disorders with compounds having selectivity for the alpha 3 subunit of the benzodiazepine receptor
#1710Cardiovascular compositions and methods using combinations of anti-platelet agents
#1711Synergistic compositions and methods for enhancing potency and/or for prolonging the duration of action of anesthetics
#1712Use of allantoin as a pro-collagen synthesis agent in cosmetic compositions
#1713METHODS OF PROMOTING OSTEOGENESIS
#1714Multiple Unit Oral Sustained Release Preparation and Production Method Thereof
#1715Treatment Product for Animals and Means for Preparing Same
#1716Serotonin antagonist compositions and methods for the local inhibition of pain and inflammation
#1717Compounds as opioid receptor modulators
#1718ION CHANNEL MODULATORS
#1719Metallo-β-lactamase inhibitors
#1720Oligosaccharide Aldonic Acids and Their Topical Use
#1721Prevention of Cell Proliferation by Inhibiting Myosin Light Chain Kinase
#1722BENZIMIDAZOLIDINONE DERIVATIVES AS MUSCARINIC AGENTS
#1723Malonyl-CoA Decarboxylase Inhibitors Useful as Metabolic Modulators
#1724Skin external preparation
#1725Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK
#1726Delivery of H2 Antagonists
#1727Compositions and Methods for Preventing and Treating Skin and Hair Conditions
#1728Treatment of pain by inhibition of p38 map kinase
#1729Compositions and methods for topical diagnostic and therapeutic transport
#1730Modified azole compounds as antifungal and antibacterial agents
#1731Bioavailability and Improved Delivery of Alkaline Pharmaceutical Drugs
#1732Gastric acid secretion inhibiting composition
#1733COSMETIC AND PHARMACEUTICAL FOAM
#1734METHODS FOR TREATING CYSTIC KIDNEY DISEASE
#1735Protection From And Treatment Of Prion Protein Infection
#1736Novel Regimens for Treating Diseases and Disorders
#1737METHODS FOR PREVENTING, POSTPONING OR IMPROVING THE OUTCOME OF SPINAL DEVICE AND FUSION PROCEDURES
#1738Methods for Preventing, Postponing or Improving the Outcome of Invasive Spinal Procedures
#1739Methods of treating diarrhea and bloating caused by small intestinal bacterial overgrowth
#1740Methods of treating fibromyalgia caused by small intestinal bacterial overgrowth
#1741BENZIMIDAZOLIDINONE DERIVATIVES AS MUSCARINIC AGENTS
#1742METHODS TO PREVENT AND TREAT DISEASES
#1743LYOPHILIZED PHARMACEUTICAL COMPOSITION
#1744Method for treating proliferative disorders with HSP90 inhibitors
#1745Treatment of depressive disorders
#1746Azole derivatives and pharmaceutical compositions containing them
#1747Anti-infection augmentation foamable compositions and kit and uses thereof
#1748Use Of Metronidazole For Preparing A Pharmaceutical Composition For Treating A Cutaneous Inflammation
#1749Method for treatment of neurodegenerative disorders
#1750Medicament for Preventing and/or Treating Ischemic Cardiovascular Disease
#1751Combination Therapy with Parp Inhibitors
#1752Sequence selective pyrrole and imidazole polyamide metallocomplexes
#1753Protein Binding Compounds
#1754Combinations for the treatment of rheumatoid arthritis
#1755Antiviral drugs for treatment of arenavirus infection
#1756Oral antimicrobial pharmaceutical compositions
#1757Use of Metronidazole for Preparing a Pharmaceutical Composition for Treating a Cutaneous Vascularisation Disorder
#1758BRIMONIDINE AND TIMOLOL COMPOSITIONS
#1759Iron binding agents
#1760INTRAVAGINAL TREATMENT OF VAGINAL INFECTIONS WITH METRONIDAZOLE COMPOSITIONS
#1761COMPOSITION AND METHOD OF USE THEREOF
#1762Metronidazole/azelaic acid compositions for the treatment of rosacea
#1763Nitrogen-containing heterocycle derivatives, pharmaceutical compositions, and methods of use thereof as antiviral agents
#1764NOVEL NON-PSYCHOTROPIC CANNABINOIDS
#17652-NH-HETEROARYLIMIDAZOLES WITH ANTIBACTERIAL ACTIVITY
#1766Tablet Formulations and Processes
#1767Imidazole-based compounds, compositions comprising them and methods of their use
#1768Stable Pharmaceutical Compositions and Methods of Making and Using Same
#1769Aryl imidazoles and related compounds as C5a receptor modulators
#1770Use of Memantine and Brimonidine to Attenuate Vitreoretinal Vascular Endothelial Growth Factor (VEGF) Protein Levels in Animals
#1771Pharmaceutical Formulations
#1772Method for the treatment of CNS disorders with substituted 2-imidazoles or imidazole derivatives
#1773Method for treating central nervous system disorders with substituted 2-imidazoline derivatives
#1774Remedies for prostatic hypertrophy
#1775Ion channel modulators
#1776HETEROCYCLIC MODULATORS OF PPAR
#1777Treatment or prevention of hypotension and shock
#1778β2-adrenergic receptor agonists
#1779Treatment of diseases associated with the use of antibiotics
#1780Process for producing pellets for pharmaceutical compositions
#1781Methods for treating irritable bowel syndrome
#1782Aralkyl ester soft drugs
#17832,4,5-trisubstituted imidazoles and their use as anti-microbial agents
#1784Azithromycin for treatment of granulomatous rosacea
#1785Imidazole derivatives modulating the sodium channels
#1786Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging
#1787Active substance combination comprising a carbinol combined to at least an NSAID
#1788Imidazole compounds that modulate HSP90 activity
#1789Active substance combination
#1790Method of treatment of otitis externa
#1791Substituted 2-aminotetralin for the treatment of depression
#1792Aniline derivatives
#1793Lofexidine
#1794Methods and therapies for potentiating a therapeutic action of an opioid receptor agonist and inhibiting and/or reversing tolerance to opioid receptor agonists
#1795Oral care compositions containing combinations of anti-bacterial and host-response modulating agents
#1796Ectoparasiticidal formulations of spinosyms and azole pesticides
#1797Method of treating fibrotic diseases or other indications with imidazolium agents
#1798Pharmaceutical compositions comprising alpha-2-adrenergics and trefoil factor family peptides
#1799Gastric acid secretion inhibiting composition
#1800Methods of treating cognitive dysfunction by modulating brain energy metabolism